Larimar Therapeutics: Nomlabofusp Program Update Expected Mid-Dec to Include Available Safety, Pharmacokinetic and Frataxin Data >LRMR
Larimar Therapeutics: Nomlabofusp Program Update Expected Mid-Dec to Include Available Safety, Pharmacokinetic and Frataxin Data >LRMR
larimar therapeutics：Nomlabofusp項目更新預計於12月中旬發佈，包括可用的安全性、藥代動力學和Frataxin數據>LRMR
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登入免費觀看全文
登入/註冊
資訊熱榜
更新時間